Apr24030 Best HealthTech Investment Company 2024 – Canada Wealth & Finance Responsible Investing Excellence Award 2024 To some, ethical finance means creating meaningful value for a variety of companies across an endless array of industries. To others, however, it has a much more profound meaning – one that sees it completely transforming the lives of underserved populations. Cross-Border Impact Ventures is one such entity that, through its impact-driven ideology, promises to encourage the delivery of scalable healthcare technology solutions to women, children, and adolescents alike. Join us as we explore how Cross-Border Impact Ventures has completely altered the course of the HealthTech investment sphere. Founded in 2021 in response to Canada’s need for an impact-driven venture capital firm who was prepared to tighten its focus on scalable healthcare technology solutions, Cross-Border Impact Ventures is an award-winning entity that prides itself on what it does differently. While most HealthTech investors may only concern themselves with broader solutions suited to the masses, Cross-Border Impact Ventures instead has its sights on supporting solutions that hold the greatest potential for large scale adoption for the primary benefit of women, children, and adolescents. It accomplishes this through what it defines as a ‘gender lens’ – a scope that channels its investment interest into a more concentrated process. As a result of this approach, Cross-Border Impact Ventures is able to strictly invest in technologies that are both applicable to emerging markets, as well as pre-existing ones. In addition, it also carries out a rigorous assessment process to guarantee subsequent success across both seeking returns and meeting its impact target – improving the lives of 8 million women and children in an abundance of emerging markets across the globe. “CBIV is intent on showcasing that it is possible to make money while doing good things for people around the globe.” When we consulted Cross-Border Impact Ventures on how it aligns itself with its own meaning of ‘ethical finance’, it had this to say – “CBIV - and our Women’s and Children’s Health Technology Fund - is changing the way investors view reaching underserved populations around the world with the newest and most effective health technologies within their portfolios, with emphasis on women, children and adolescents. We do this by investing in novel technology solutions that are, among other things, cost effective, easier to use by health practitioners, more convenient - and/or less painful for patients – and, most importantly, will have a material health outcome improvement on their lives.” Powered by selflessness, it’s clear that Cross-Border Impact Ventures is well on its way to securing a better tomorrow for those who have previously been let down by the healthcare sphere. With portfolio companies typically based in North America and Europe – ones that have already pledged to fulfil the promises made through their respective impact goals in low and middle-income countries – Cross-Border Impact Ventures works closely to secure the funding needed to make such a tangible change. Thankfully, the collective has avidly worked to establish connections with a steadfast network of foundations, donors, and investors, allowing it provide support to those hoping to establish new programs across the world. In short, Cross-Border Impact Ventures aims to inspire others to rethink how they could have a positive impact on the wider world, with its previous achievements demonstrating this mentality time and time again. Whether it’s assisting its portfolio companies with their fundraising strategies or playing a key role in helping them to carefully consider their capital structure in creative ways that are bound to attract investors and funders within the health space, Cross-Border Impact Ventures is a master of encouraging others to thrive. For far too long, underserved groups have been completely overshadowed by the masses, leaving them without access to the fundamental healthcare solutions they deserve. Thankfully, Cross-Border Impact Ventures has onboarded the task of reinventing how investors within the sphere have positioned themselves and grants them the opportunities needed to change. Combined, these traits create an awardwinning collective whose impact will surely be felt far and wide the further its influence spreads. We sincerely look forward to the day that, through Cross-Border Impact Ventures’ work, women, children, and adolescents alike can finally gain access to the healthcare they’ve always been owed. Contact: Annie Thériault Company: Cross-Border Impact Ventures Web Address: www.crossborder.ventures “Cross-Border Impact Ventures team, from left to right: Pooja Sikka (Venture Partner), Cyriac Alappat (Principal), Megan Dover (Principal), Annie Thériault (Managing Partner), Donna Parr (Managing Partner), Hamza Kayani (Investment Analyst), Hannah Sharpe (ESG and Health Impact Associate), Tasha Noronha (Partnerships and Operations Manager), Juanita Cortés (Chief Financial Officer)” Cross-Border Impact Ventures
RkJQdWJsaXNoZXIy MTUyMDQwMA==